Skip to main content
. 2021 Mar 3;106(5):716–723. doi: 10.1111/ejh.13603

TABLE 3.

Outcomes during follow‐up

Death 24 (24.0%)
COVID‐19 (respiratory failure) 15 (15.0%)
PE 5 (5.0%)
Bleeding 2 (2.0%)
Cancer 1 (1.0%)
Unknown 1 (1.0%)
VTE recurrence 0 (0.0%)
Bleeding 20 (20.0%)
Major bleeding 11 (11.0%)
Location of bleeding (n = 20)
Hematoma 4 (4.0%)
Cerebral 3 (3.0%)
Retroperitoneal 3 (3.0%)
Muscular 2 (2.0%)
Urinary 2 (2.0%)
Gastrointestinal 1 (1.0%)
Other 5 (4.0%)

Abbreviations: PE, pulmonary embolism; VTE, venous thromboembolism.